Development and validation of multivariate models integrating preoperative clinicopathological and radiographic findings to predict HER2 status in gastric cancer

The combination of trastuzumab and chemotherapy is recommended as first-line therapy for patients with human epidermal growth factor receptor 2 (HER2) positive advanced gastric cancers (GCs). Successful trastuzumab-induced targeted therapy should be based on the assessment of HER2 overexpression. Th...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Mengying, Liu, Song, Li, Lin, Qiao, Xiangmei, Ji, Changfeng, Tan, Lingyu, Zhou, Zhengyang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9391326/
https://www.ncbi.nlm.nih.gov/pubmed/35986169
http://dx.doi.org/10.1038/s41598-022-18433-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9391326/
https://www.ncbi.nlm.nih.gov/pubmed/35986169
http://dx.doi.org/10.1038/s41598-022-18433-z

Ejemplares similares